BIOCERES CROP SOLUTIONS CORP (BIOX) Stock Overview
NASDAQ:BIOX - KYG1117K1141 - Common Stock
BIOX Key Statistics, Chart & Performance
The current stock price of BIOX is 2.485 USD. In the past month the price decreased by -19.84%. In the past year, price decreased by -70.97%.
BIOX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CTVA | CORTEVA INC | 22.7 | 48.71B | ||
| NTR | NUTRIEN LTD | 16.49 | 27.72B | ||
| CF | CF INDUSTRIES HOLDINGS INC | 11.23 | 13.57B | ||
| MOS | MOSAIC CO/THE | 18.13 | 10.30B | ||
| ICL | ICL GROUP LTD | 16.38 | 7.82B | ||
| FMC | FMC CORP | 11.07 | 4.63B | ||
| SMG | SCOTTS MIRACLE-GRO CO | 18.51 | 3.60B | ||
| UAN | CVR PARTNERS LP | 10.61 | 933.33M | ||
| IPI | INTREPID POTASH INC | 49.53 | 389.21M | ||
| AVD | AMERICAN VANGUARD CORP | N/A | 159.49M | ||
| GRO | BRAZIL POTASH CORP | N/A | 77.85M | ||
| ENFY | ENLIGHTIFY INC | N/A | 15.49M |
Related stock screener links
About BIOX
Company Profile
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The company is headquartered in Rosario, Santa Fe and currently employs 983 full-time employees. The company went IPO on 2018-03-22. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.
Company Info
BIOCERES CROP SOLUTIONS CORP
Ocampo 210 bis, Predio CCT
Rosario SANTA FE 2000 AR
CEO: Federico Trucco
Employees: 389
Phone: 543414861100
BIOCERES CROP SOLUTIONS CORP / BIOX FAQ
What is the stock price of BIOCERES CROP SOLUTIONS CORP today?
The current stock price of BIOX is 2.485 USD. The price decreased by -8.3% in the last trading session.
What is the ticker symbol for BIOCERES CROP SOLUTIONS CORP stock?
The exchange symbol of BIOCERES CROP SOLUTIONS CORP is BIOX and it is listed on the Nasdaq exchange.
On which exchange is BIOX stock listed?
BIOX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for BIOCERES CROP SOLUTIONS CORP stock?
10 analysts have analysed BIOX and the average price target is 7.52 USD. This implies a price increase of 202.72% is expected in the next year compared to the current price of 2.485. Check the BIOCERES CROP SOLUTIONS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIOCERES CROP SOLUTIONS CORP worth?
BIOCERES CROP SOLUTIONS CORP (BIOX) has a market capitalization of 155.83M USD. This makes BIOX a Micro Cap stock.
How many employees does BIOCERES CROP SOLUTIONS CORP have?
BIOCERES CROP SOLUTIONS CORP (BIOX) currently has 389 employees.
What are the support and resistance levels for BIOCERES CROP SOLUTIONS CORP (BIOX) stock?
BIOCERES CROP SOLUTIONS CORP (BIOX) has a resistance level at 2.76. Check the full technical report for a detailed analysis of BIOX support and resistance levels.
Is BIOCERES CROP SOLUTIONS CORP (BIOX) expected to grow?
The Revenue of BIOCERES CROP SOLUTIONS CORP (BIOX) is expected to decline by -21.79% in the next year. Check the estimates tab for more information on the BIOX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BIOCERES CROP SOLUTIONS CORP (BIOX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BIOX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BIOX, evaluating the profitability, health, valuation and growth aspects
- BIOCERES CROP SOLUTIONS CORP (BIOX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOCERES CROP SOLUTIONS CORP (BIOX) Sales and EPS estimates to see what analysts future expectations are.
- BIOCERES CROP SOLUTIONS CORP (BIOX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOCERES CROP SOLUTIONS CORP (BIOX) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOCERES CROP SOLUTIONS CORP (BIOX) Stock Chart to make your own analysis
- BIOCERES CROP SOLUTIONS CORP (BIOX) Latest news and press-releases to stay up to date.
Does BIOCERES CROP SOLUTIONS CORP (BIOX) stock pay dividends?
BIOX does not pay a dividend.
When does BIOCERES CROP SOLUTIONS CORP (BIOX) report earnings?
BIOCERES CROP SOLUTIONS CORP (BIOX) will report earnings on 2025-09-09, before the market open.
What is the Price/Earnings (PE) ratio of BIOCERES CROP SOLUTIONS CORP (BIOX)?
BIOCERES CROP SOLUTIONS CORP (BIOX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.13).
What is the Short Interest ratio of BIOCERES CROP SOLUTIONS CORP (BIOX) stock?
The outstanding short interest for BIOCERES CROP SOLUTIONS CORP (BIOX) is 1.16% of its float. Check the ownership tab for more information on the BIOX short interest.
BIOX Technical Analysis
BIOX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BIOX. BIOX may be in some trouble as it scores bad on both profitability and health.
BIOX Financial Highlights
Over the last trailing twelve months BIOX reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS decreased by -551.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.13% | ||
| ROE | -2.94% | ||
| Debt/Equity | 0.28 |
BIOX Forecast & Estimates
10 analysts have analysed BIOX and the average price target is 7.52 USD. This implies a price increase of 202.72% is expected in the next year compared to the current price of 2.485.
For the next year, analysts expect an EPS growth of -212.37% and a revenue growth -21.79% for BIOX